Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) gapped up prior to trading on Monday following insider buying activity. The stock had previously closed at $36.45, but opened at $39.98.

Strategic Investment Report for TD Global Technology Leaders CAD Hedged Index ETF (TECX) Highlighting Buy and Sell Opportunities ...

Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) have been given an average recommendation of “Buy” by the six ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Tectonic Therapeutic (TECX – Research Report), with a ...

Investment Strategy and Analysis for TD Global Technology Leaders CAD Hedged Index ETF (TECX) with Buy/Sell Signals ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has announced a significant $185 million private placement financing. The private ...

WATERTOWN, Mass. - Tectonic Therapeutic, Inc. (NASDAQ: TECX), a biotechnology company specializing in the development of therapeutic proteins and antibodies, announced today that it has entered into a ...

Inc. (NASDAQ: TECX) (“Tectonic”), today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the “PIPE”) that is expected to result ...

Detailed price information for TD Global Tech Leaders CAD Hdg Idx ETF (TECX-T) from The Globe and Mail including charting and trades.

Shares of Tectonic Therapeutic Inc. (NASDAQ:TECX) closed Jan. 30 at $54.84, up $29.12, or 113%, on what Leerink analyst David ...